Most Chinese biotechnology stocks have been in a downward channel but not SSRX. This stock has been in an upward channel since last September, which means it moved more with the U.S. market rather than the Chinese pharmaceutical market over the past eight months. The stock saw strong volume come in all this week especially on Thursday in which SSRX almost reached a 52-week high. On Friday, Oppenheimer said the Chinese biotech/pharma space was a buying opportunity on recent weakness and outlined that buying should move first into the leader of the sector - that would be SSRX.
Click to enlarge
Price Target: $19.00
Support: $16.92
http://seekingalpha.com/article/265251-looking-ahead-to-the-trading-week-stocks-and-charts-to-watch?source=yahoo
FEATURED Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • May 8, 2024 9:05 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • BLOZF • May 7, 2024 8:51 AM